ログイン

PHARMA

Nervous system

PHARMA
34問 • 1年前Nervous system
  • Jp Lechago
  • 通報

    問題一覧

  • 1

    Controlling the functions of the human body

    NERVOUS SYSTEM

  • 2

    STRUCTURAL UNIT OF NERVOUS SYSTEM

    NEURONS

  • 3

    THIS IS THE FIRST NEUROTRANSMITTER DISCOVERED WHICH IS FOUND IN THE BRAIN, SPINAL CORD AND PARTICULARLY AT THE NEUROMUSCULAR JUNCTION OF THE SKELETAL MUSCLE OF THE PERIPHERAL NERVOUS SYSTEM.

    ACETYLCHOLINE

  • 4

    ACETYLCHOLINE SIGNALS MUSCLES TO BECOME ACTIVE INCLUDING THE MUSCLES OF THE GI.

    MUSCULAR STIMULATION

  • 5

    THE MOST PREDOMINANT NEUROTRANSMITTER IN THE NERVOUS SYSTEM. ALSO KNOWN AS NORADRENALINE PRIMARY LOCATED IN BRAIN STEM AND SYMPATHETIC NERVOUS SYSTEM

    NOREPINEPHRINE

  • 6

    SYNTHESIZED FROM TYROSINE WHICH IS DIETARY AMINO ACID

    DOPAMINE

  • 7

    MAJOR INHIBITORY NEUROTRANSMITTER IN THE BRAIN

    GABA

  • 8

    EXCITATORY AMINO ACID AND PLAYS AN IMPORTANT PART IN REGARDS TO MEMORY

    GLUTAMATE

  • 9

    NEUROTRANSMITTER ONLY FOUND IN THE BRAIN AND PLAYS A VERY IMPORTANT ROLE IN RANGE OF VARIOUS BRAIN FUNCTION. IT IS DERIVED FROM THE DIETARY AMINO ACID, TRYPTOPHAN.

    SEROTONIN

  • 10

    COMPOST OF BRAIN AND SPINAL CORD

    CENTRAL NERVOUS SYSTEM

  • 11

    RESPIRATORY CENTERS, WHICH CONTROL BREATHING.

    HINDBRAIN

  • 12

    STIMULATES THE CEREBRAL CORTEX OF THE BRAIN

    AMPHETAMINES

  • 13

    WHICH ACT ON THE BRAINSTEM AND MEDULLA TO STIMULATE RESPIRATION.

    ANALEPTICS

  • 14

    SUPPRESS APPETITE BY STIMULATING THE SAFIETY CENTER IN THE HYPOTHALAMIC AND LIMBIC AREAS OF THE BRAIN.

    ANOREXIANTS

  • 15

    STIMULATES THE RELEASE OF THE NEUROTRANSMITTERS NOREPINEPHRINE AND DOPAMINE FROM THE BRAIN AND SYMPATHETIC NERVOUS SYSTEM AND BLOCK THE REUPTAKE OF THESE TRANSMITTER.

    AMPHETAMINES

  • 16

    FALLING ASLEEP DURING NORMAL WALKING ACTIVITIES

    NARCOLEPSY

  • 17

    THESE DRUGS HAVE A HIGH POTENTIAL FOR ABUSE, TOLERANCE, AND DEPENDENCE

    AMPHETAMINES

  • 18

    PRESCRIBED FOR NARCOLEPSY AND ADHD

    AMPHETAMINES

  • 19

    IT INCLUDES INATTENTIVESNESS, INABILITY TO COOPERATE, RESTLESNESS, HYPERACTIVITY, AND INABILITY TO COMPLETE TASKS, AND IMPULSIVITY

    ADHD

  • 20

    THE PRIMARY USE OF AN ANALEPTIC IS TO STIMULATE RESPIRATION

    ANALEPTICS

  • 21

    Common side effects, IT IS RESIDUAL DROWSINESS RESULTING IN IMPAIRED REACTION TIME. THE INTERMEDIATE AND LONG ACTING HYPNOTICS ARE FREQUENTLY THE CAUSE.

    HANGOVER

  • 22

    IT RESULTS IN VIVID DREAMS AND NIGHTMARES, FREQUENTLY OCCURS AFTER TAKING A HYPNOTIC FOR PROLONG PERIOD THEN ABRUPTLY STOPPING.

    REM REBOUND

  • 23

    THE RESULT OF CHRONIC HYPNOTIC USE. PHYSICAL AND PSYCHOLOGICAL DEPENDENCE AND RESULT.

    DEPENDANCE

  • 24

    THERE IS A NEED TO INCREASE THE DOSAGE OVER TIME TO OBTAIN DESIRED EFFECTS.

    TOLERANCE

  • 25

    RESULT IN CNS DEPERESION

    EXCESSIVE DEPRESSION

  • 26

    HIGH DOSES OF SEDATIVE HYPNOTICS CAN SUPPRESS THE RESPIRATORY CENTER IN THE MEDULLA.

    RESPIRATORY DEPRESSION

  • 27

    SKIN RASHES AND URTICARIA CAN RESULT WHEN TAKING BARBITURATES, SUCH REACTIONS ARE RARE.

    HYPERSENSITIVITY

  • 28

    LONG-ACTING GROUP INCLUDES PHENOBARBITAL, WHICH IS USED TO CONTROL SEIZURES IN EPILEPSY.

    BARBITURATES

  • 29

    THE MOST FREQUENT USED ANXIOLYTIC DRUGS, PREVENTING ANXIETY WITHOUT CAUSING MUCH AASOCIATED SEDATION.

    BENZODIAZEPINES

  • 30

    THIS GROUP IS ORDERED AS SEDATIVE-HYPNOTICS FOR INDUCING SLEEP.

    BENZODIAZEPINES

  • 31

    INCREASE THE ACTION OF THE INHIBITORY NEUROTRANSMITTER GABA

    BENZODIAZEPINES

  • 32

    PROMETHEGAN, DIPHENHYDRAMINE

    ANTIHISTAMINE

  • 33

    A NEWER ANTIANXIETY AGENT, HAS NO SEDATIVE, ANTICONVULSANT, OR MUSCLE-RELAXANT PROPERTIES, AND ITS MECHANISMS OF ACTION IS UNKNOWN.

    BUSPIRONE

  • 34

    IT REDUCES THE SIGNS AND SYMPTOMS OF ANXIETY WITHOUT MANY OF THE CNS EFFECTS AND SEVERE ADVERSE EFFECTS ASSOCIATED WITH OTHER ANXIOLYTIC DRUGS.

    BUSPIRONE

  • DUTY - VRP ABBREVIATIONS

    DUTY - VRP ABBREVIATIONS

    Jp Lechago · 35問 · 1年前

    DUTY - VRP ABBREVIATIONS

    DUTY - VRP ABBREVIATIONS

    35問 • 1年前
    Jp Lechago

    BIO ETHICS

    BIO ETHICS

    Jp Lechago · 46問 · 1年前

    BIO ETHICS

    BIO ETHICS

    46問 • 1年前
    Jp Lechago

    BIO ETHICS - 2ND - Sexuality

    BIO ETHICS - 2ND - Sexuality

    Jp Lechago · 31問 · 1年前

    BIO ETHICS - 2ND - Sexuality

    BIO ETHICS - 2ND - Sexuality

    31問 • 1年前
    Jp Lechago

    MCN 104 - LECTURE WEEK 8

    MCN 104 - LECTURE WEEK 8

    Jp Lechago · 7問 · 1年前

    MCN 104 - LECTURE WEEK 8

    MCN 104 - LECTURE WEEK 8

    7問 • 1年前
    Jp Lechago

    HEALTH SECTOR REFORM

    HEALTH SECTOR REFORM

    Jp Lechago · 19問 · 1年前

    HEALTH SECTOR REFORM

    HEALTH SECTOR REFORM

    19問 • 1年前
    Jp Lechago

    NUTRITION - EXAM

    NUTRITION - EXAM

    Jp Lechago · 67問 · 1年前

    NUTRITION - EXAM

    NUTRITION - EXAM

    67問 • 1年前
    Jp Lechago

    Pharma - Midterm Exam

    Pharma - Midterm Exam

    Jp Lechago · 10問 · 1年前

    Pharma - Midterm Exam

    Pharma - Midterm Exam

    10問 • 1年前
    Jp Lechago

    問題一覧

  • 1

    Controlling the functions of the human body

    NERVOUS SYSTEM

  • 2

    STRUCTURAL UNIT OF NERVOUS SYSTEM

    NEURONS

  • 3

    THIS IS THE FIRST NEUROTRANSMITTER DISCOVERED WHICH IS FOUND IN THE BRAIN, SPINAL CORD AND PARTICULARLY AT THE NEUROMUSCULAR JUNCTION OF THE SKELETAL MUSCLE OF THE PERIPHERAL NERVOUS SYSTEM.

    ACETYLCHOLINE

  • 4

    ACETYLCHOLINE SIGNALS MUSCLES TO BECOME ACTIVE INCLUDING THE MUSCLES OF THE GI.

    MUSCULAR STIMULATION

  • 5

    THE MOST PREDOMINANT NEUROTRANSMITTER IN THE NERVOUS SYSTEM. ALSO KNOWN AS NORADRENALINE PRIMARY LOCATED IN BRAIN STEM AND SYMPATHETIC NERVOUS SYSTEM

    NOREPINEPHRINE

  • 6

    SYNTHESIZED FROM TYROSINE WHICH IS DIETARY AMINO ACID

    DOPAMINE

  • 7

    MAJOR INHIBITORY NEUROTRANSMITTER IN THE BRAIN

    GABA

  • 8

    EXCITATORY AMINO ACID AND PLAYS AN IMPORTANT PART IN REGARDS TO MEMORY

    GLUTAMATE

  • 9

    NEUROTRANSMITTER ONLY FOUND IN THE BRAIN AND PLAYS A VERY IMPORTANT ROLE IN RANGE OF VARIOUS BRAIN FUNCTION. IT IS DERIVED FROM THE DIETARY AMINO ACID, TRYPTOPHAN.

    SEROTONIN

  • 10

    COMPOST OF BRAIN AND SPINAL CORD

    CENTRAL NERVOUS SYSTEM

  • 11

    RESPIRATORY CENTERS, WHICH CONTROL BREATHING.

    HINDBRAIN

  • 12

    STIMULATES THE CEREBRAL CORTEX OF THE BRAIN

    AMPHETAMINES

  • 13

    WHICH ACT ON THE BRAINSTEM AND MEDULLA TO STIMULATE RESPIRATION.

    ANALEPTICS

  • 14

    SUPPRESS APPETITE BY STIMULATING THE SAFIETY CENTER IN THE HYPOTHALAMIC AND LIMBIC AREAS OF THE BRAIN.

    ANOREXIANTS

  • 15

    STIMULATES THE RELEASE OF THE NEUROTRANSMITTERS NOREPINEPHRINE AND DOPAMINE FROM THE BRAIN AND SYMPATHETIC NERVOUS SYSTEM AND BLOCK THE REUPTAKE OF THESE TRANSMITTER.

    AMPHETAMINES

  • 16

    FALLING ASLEEP DURING NORMAL WALKING ACTIVITIES

    NARCOLEPSY

  • 17

    THESE DRUGS HAVE A HIGH POTENTIAL FOR ABUSE, TOLERANCE, AND DEPENDENCE

    AMPHETAMINES

  • 18

    PRESCRIBED FOR NARCOLEPSY AND ADHD

    AMPHETAMINES

  • 19

    IT INCLUDES INATTENTIVESNESS, INABILITY TO COOPERATE, RESTLESNESS, HYPERACTIVITY, AND INABILITY TO COMPLETE TASKS, AND IMPULSIVITY

    ADHD

  • 20

    THE PRIMARY USE OF AN ANALEPTIC IS TO STIMULATE RESPIRATION

    ANALEPTICS

  • 21

    Common side effects, IT IS RESIDUAL DROWSINESS RESULTING IN IMPAIRED REACTION TIME. THE INTERMEDIATE AND LONG ACTING HYPNOTICS ARE FREQUENTLY THE CAUSE.

    HANGOVER

  • 22

    IT RESULTS IN VIVID DREAMS AND NIGHTMARES, FREQUENTLY OCCURS AFTER TAKING A HYPNOTIC FOR PROLONG PERIOD THEN ABRUPTLY STOPPING.

    REM REBOUND

  • 23

    THE RESULT OF CHRONIC HYPNOTIC USE. PHYSICAL AND PSYCHOLOGICAL DEPENDENCE AND RESULT.

    DEPENDANCE

  • 24

    THERE IS A NEED TO INCREASE THE DOSAGE OVER TIME TO OBTAIN DESIRED EFFECTS.

    TOLERANCE

  • 25

    RESULT IN CNS DEPERESION

    EXCESSIVE DEPRESSION

  • 26

    HIGH DOSES OF SEDATIVE HYPNOTICS CAN SUPPRESS THE RESPIRATORY CENTER IN THE MEDULLA.

    RESPIRATORY DEPRESSION

  • 27

    SKIN RASHES AND URTICARIA CAN RESULT WHEN TAKING BARBITURATES, SUCH REACTIONS ARE RARE.

    HYPERSENSITIVITY

  • 28

    LONG-ACTING GROUP INCLUDES PHENOBARBITAL, WHICH IS USED TO CONTROL SEIZURES IN EPILEPSY.

    BARBITURATES

  • 29

    THE MOST FREQUENT USED ANXIOLYTIC DRUGS, PREVENTING ANXIETY WITHOUT CAUSING MUCH AASOCIATED SEDATION.

    BENZODIAZEPINES

  • 30

    THIS GROUP IS ORDERED AS SEDATIVE-HYPNOTICS FOR INDUCING SLEEP.

    BENZODIAZEPINES

  • 31

    INCREASE THE ACTION OF THE INHIBITORY NEUROTRANSMITTER GABA

    BENZODIAZEPINES

  • 32

    PROMETHEGAN, DIPHENHYDRAMINE

    ANTIHISTAMINE

  • 33

    A NEWER ANTIANXIETY AGENT, HAS NO SEDATIVE, ANTICONVULSANT, OR MUSCLE-RELAXANT PROPERTIES, AND ITS MECHANISMS OF ACTION IS UNKNOWN.

    BUSPIRONE

  • 34

    IT REDUCES THE SIGNS AND SYMPTOMS OF ANXIETY WITHOUT MANY OF THE CNS EFFECTS AND SEVERE ADVERSE EFFECTS ASSOCIATED WITH OTHER ANXIOLYTIC DRUGS.

    BUSPIRONE